How Family and Friends Influence Breast Cancer Treatment Decisions

A new study finds half of early stage breast cancer patients relied on three or more people to help them process treatment options.

7:00 AM

Author | Nicole Fawcett

When a woman walks into an oncologist's office, she's usually not alone. In fact, a new study finds that half of women have at least three people standing behind them, sitting next to them or waiting at home to help face cancer.

MORE FROM THE LAB: Subscribe to our weekly newsletter

In most cases, these support people are going with the patient to appointments, taking notes, finding additional resources and helping talk through treatment options.

"People just diagnosed with cancer are often scared and overwhelmed. Having another person to help them process information is important," says Lauren P. Wallner, Ph.D., MPH, assistant professor of general medicine and epidemiology at the University of Michigan. Wallner is the lead author of the paper, published in the journal Cancer.

"Physicians need to recognize that women involve other people in their treatment decisions. These people represent an important group to provide treatment information to," Wallner notes.

The study surveyed 2,502 women with early stage breast cancer about two months after they had surgery. Women were asked to list specific individuals who were involved in helping them make a treatment decision.

Half of the respondents listed at least three people and 20 percent listed two people. Only 10 percent said they had no personal decision support network. Nearly three-quarters of women said their support network talked with them about their treatment options and frequently attended their appointments.

African-American and Latina women reported larger networks than white women. Women who were married or partnered also reported more support.

Even among women without a partner or spouse, many had large support networks. Women reported children, friends, siblings, parents and other relatives as involved in decision-making.

"Minority women tend to have larger networks, so clinicians should also be aware that there could be differences in the number of people patients might be involving. And these networks go beyond just a partner or spouse," Wallner says.

Larger support networks were associated with more deliberation about treatment, which the researchers suggest could be critical as treatment options become more complex. More deliberation suggests patients are thinking through pros and cons, discussing it with others and weighing the decision carefully.

"When patients are diagnosed with cancer, there's this rush to get through the treatment process. But for patients with early stage breast cancer, they have some time to decide on their treatment choice," Wallner says.

"The idea that women are discussing their options more with their family and friends and potentially thinking through that decision more carefully is reassuring. Engaging these informal support networks could be a way to prevent women from rushing into something," she says.

The idea that women are discussing their options more with their family and friends and potentially thinking through that decision more carefully is reassuring.
Lauren P. Wallner, Ph.D., MPH

Speaking to supporters

The researchers recommend physicians incorporate family and friends into the conversation, delivering information and decision aids to everyone in the room, as well as providing information that can be shared with those back at home.

SEE ALSO: One-Third of Breast Cancer Patients Consult PCPs About Treatment Options

Typically, decision aids and other materials are written for the patient. Wallner says this study suggests the need to broaden these materials to include family and friends who play a role in helping a woman understand her treatment choices. 

"When considering these complex treatment options and going through these complex decisions, it's beneficial to have the support of other people. This helps women feel supported in their decisions," Wallner says.

At the same time, women without a support network may need extra help or information during the decision process, Wallner points out.

"It starts with something as simple as physicians asking patients who is helping them make their treatment decisions. That can then guide the conversation, such as the amount of resources the physician provides and to whom they communicate that information," she says.


More Articles About: Rounds Breast cancer Cancer: Cancer Types
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories two women looking at eachother red shirt blue patient covering
Health Lab
Chronic health conditions associated with worse survival rates for patients with metastatic breast cancer
Black women are at the highest risk of death.
Breast cancer scan image
Health Lab
Annual Over Biennial Mammograms Linked to Less Advanced Breast Cancer
Mammograms, an essential part of breast cancer screening, could increase overall health outcomes if performed annually according to a new study.
Health Lab
Surgeons Influence Receipt of Genetic Testing After Breast Cancer Diagnosis
Surveys of patients and their surgeons showed genetic testing rates ranged from 26 to 72 percent, depending on the surgeon.
Health Lab
Risks, Outcomes Differ Depending on Breast Reconstructive Surgery Type
In a new study of breast cancer patients who had breast reconstruction, researchers examine complications across the different types of surgeries.
Health Lab
Some Breast Cancer Patients Missing Out on Genetic Counseling
A new study finds only half of women who could benefit from genetic testing get it, and often not before they have surgery.
Health Lab
Study Finds Double Mastectomy Tied to More Missed Work
A new study finds that women who pursue aggressive cancer treatments, like double mastectomy, are eight times more likely to have substantial employment disruptions.